Apr 29, 2019 / 12:00PM GMT
Operator
Greetings, welcome to Innovate Biopharmaceuticals First Quarter 2019 Financial Results and to Provide Operational Progress Conference Call. I will now turn the conference over to your host, Jen Zimmons. Thank you. You may begin.
Jennifer K. Zimmons - Strategic Growth International, Inc. - MD
Thank you, operator. Good morning, and thank you for joining us to discuss our recent business progress and Innovate Biopharmaceuticals' 2019 First Quarter Results and Operational Progress Updates Conference Call. The press release containing the company's financial results for Q1 2019 was issued earlier this morning. Joining our call are Dr. Steve Laumas, Chairman and CEO; and Dr. Griffin, Chief Medical Officer. Jay Madan, President and Chief business Officer will be joining the Q&A session.
Before we begin, I'd like to remind everyone that this conference call includes forward-looking statements. Each forward-looking statement contained in this call is subject to risks and uncertainties that could cause actual results to differ materially from those described
Q1 2019 Innovate Biopharmaceuticals Inc Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers